Clearmind Medicine Inc. (CMND)
NASDAQ: CMND · Real-Time Price · USD
1.035
-0.035 (-3.27%)
At close: Mar 31, 2025, 4:00 PM
1.077
+0.042 (4.04%)
After-hours: Mar 31, 2025, 7:44 PM EDT
Clearmind Medicine Market Cap
Clearmind Medicine has a market cap or net worth of $5.31 million as of March 31, 2025. Its market cap has increased by 39.73% in one year.
Market Cap
5.31M
Enterprise Value
-555.42K
1-Year Change
39.73%
Ranking
Category
Stock Price
$1.04
Market Cap Chart
Since August 16, 2021, Clearmind Medicine's market cap has decreased from $26.17M to $5.31M, a decrease of -79.70%. That is a compound annual growth rate of -35.59%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 31, 2025 | 5.31M | -5.06% |
| Dec 31, 2024 | 5.60M | 17.66% |
| Dec 29, 2023 | 4.76M | -39.13% |
| Dec 30, 2022 | 7.82M | -59.16% |
| Dec 27, 2021 | 19.14M | -26.88% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 738.61B |
| UnitedHealth Group | 472.03B |
| Johnson & Johnson | 394.52B |
| AbbVie | 363.15B |
| Novo Nordisk | 305.46B |
| AstraZeneca | 229.16B |
| Abbott Laboratories | 226.88B |
| Merck & Co. | 225.40B |